Eye experts and scientists at the University of Southampton have discovered specific cells in the eye which could lead to a new procedure to treat and cure blinding eye conditions.
(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Journal of Medicine.
(HealthDay)—For white middle-aged adults, there may be an association between variants in a gene associated with fat mass and obesity (FTO) and memory decline, according to research published online Nov. 7 in Neurology.
(HealthDay)—A frank and graphic nationwide media campaign to motivate smokers to quit seems to be working, say researchers at the U.S. Centers for Disease Control and Prevention.
For the first time, Wisconsin researchers have taken skin from patients and, using induced pluripotent stem cell (iPSC) technology, turned them into a laboratory model for an inherited type of macular degeneration.
A research project has been studying the molecular epidemiological conditions relating to diseases caused by tuberculous and non-tuberculous mycobacteria in the Mubende region of Uganda.
Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.
Technology may soon be helping seniors to live longer, healthier lives. A trio of researchers, including Simon Fraser University's Andrew Sixsmith, is working to develop intelligent, interactive sensors to be embedded in ...
Research from the Rothman Institute at Jefferson has shown aspirin to be just as effective as warfarin in preventing clots, specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the ...
(Medical Xpress)—The most widely used models for predicting heart failure rely on a complex combination of lifestyle, demographic, and cardiovascular risk factor information.